Stay Informed – Subscribe to latest updates. We promise to send only relevant and valuable emails, just insights you care about!
Safety, Tolerability, and Preliminary Efficacy of JBZ-001 in Patients with Advanced Solid Tumors and Non-Hodgkin Lymphoma